PCN173 - Cost Minimization Analysis of The Selective Aromatase Inhibitors; Anastrozole, Versus Letrozole and Exemestane for The Management of Breast Cancer From Patient Perspective in Egypt

Autor: Assal, RA
Zdroj: In Value in Health October-November 2017 20(9):A443-A443
Databáze: ScienceDirect